Related Experiment Videos
[Advances in arterial hypertension and diabetes mellitus]
Alberto Cordero1, Iñaki Lekuona, Enrique Galve
1Departamento de Cardiología, Hospital Universitario de San Juan, Alicante, España. acorderofort@gmail.com
Insights
Hypertension and diabetes mellitus are key cardiovascular disease risk factors. Recent research highlights novel mechanisms in blood pressure and glucose metabolism influencing cardiovascular outcomes, especially concerning renal dysfunction.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Context:
- Hypertension and diabetes mellitus recognized as primary cardiovascular disease risk factors.
- Shift in research focus from large clinical trials to novel mechanisms influencing cardiovascular disease.
- Growing emphasis on public health implications of these conditions.
Purpose:
- To highlight the evolving understanding of cardiovascular disease (CVD) risk factors.
- To emphasize the shift towards mechanistic insights in CVD research.
- To underscore the significance of recent clinical trials, particularly those involving renal dysfunction.
Summary:
- In 2011, hypertension and diabetes mellitus were confirmed as major drivers of cardiovascular disease.
- Recent research has increasingly focused on novel mechanisms linking blood pressure, glucose metabolism, and diabetes to CVD.
- Clinical trials investigating renal dysfunction, such as SHARP and ROADMAP, provided crucial evidence.
Impact:
- Enhanced understanding of the interplay between metabolic disorders and cardiovascular health.
- Identification of new therapeutic targets for cardiovascular disease prevention and management.
- Informed public health strategies addressing the burden of hypertension and diabetes.
Abstract:
In 2011, the importance of hypertension and diabetes mellitus as the two main risk factors responsible for the development of cardiovascular disease became clear, as did their significance as major public health issues. Compared with previous years, in which publication of the results of large clinical trials dominated scientific progress, in the last year, the focus has shifted to evidence that novel mechanisms associated with blood pressure, glucose metabolism and diabetes can influence cardiovascular disease. Of particular importance were clinical trials in the area of renal dysfunction, such as the SHARP and ROADMAP trials.
Related Concept Videos
Diabetic Nephropathy
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction